Serum Institute to resume vaccine trials after DCGI nod
Serum Institute to resume vaccine trials after DCGI nod
IndiaTimes
0 shares
1 views
You might like
Related news coverage
Serum Institute CEO lauds PM Narendra Modi's COVID-19 vaccine vision day after challenging Centre on pandemic response
DNA
It is to be noted that the Serum Institute of India is all set to begin phase three trials of the Covishield Vaccine developed by..
-
Narendra Modi's 'pharmadiplomacy': India's COVID vaccines to 'help all humanity'
Mid-Day
-
Adar Poonawalla: Will Govt have 80,000 crores available over the next one year?
Mid-Day
-
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla
DNA
-
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks
DNA
Advertisement
More coverage
Mumbai: KEM hospital gets gets nod for COVID-19 vaccine trials
Mid-Day
The Brihanmumbai Municipal Corporation-run King Edward Memorial (KEM) Hospital on Tuesday got the approval of the Maharashtra..
-
Phase 3 trial of Oxford vaccine begins in Pune
IndiaTimes
-
Serum Institute all set to begin phase 3 trials of Covid-19 vaccine
newKerala.com
-
COVID-19 vaccination to be available by 'start of next year': Harsh Vardhan
Mid-Day
-
Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Hindu